Prostaglandin E2 stimulates insulin-like growth factor binding protein- 4 expression and synthesis in cultured human articular chondrocytes: Possible mediation by Ca++-Calmodulin regulated processes

Journal of Cellular Biochemistry

Volumn 65, Issue 3, 1997, Pages 408-419

  Di Battista, J A ^a   Dore S ^b   Morin, N ^a   He, Y ^a   Pelletier, J P ^a   Martel Pelletier, J ^a  

^a NOTRE DAME HOSPITAL   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

binding proteins; calcium; calmodulin; chondrocytes; gene expression

Indexed keywords

CALCIUM ION; CALMODULIN; COLLAGEN; CYCLIC AMP; GROWTH FACTOR; ICOSANOID; MESSENGER RNA; PROSTAGLANDIN E2; PROTEOGLYCAN; SOMATOMEDIN BINDING PROTEIN 4; SOMATOMEDIN C; CALCIUM; DEXAMETHASONE; GLUCOCORTICOID; INTERLEUKIN 1; PROTEIN KINASE C;

ARTICLE; ARTICULAR CARTILAGE; CARTILAGE CELL; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN INDUCTION; PROTEIN SYNTHESIS; BIOSYNTHESIS; CELL CULTURE; DRUG EFFECT; FEMALE; GENETICS; MALE; METABOLISM; MIDDLE AGED; PHYSIOLOGY;

CALCIUM; CALMODULIN; CARTILAGE, ARTICULAR; CELLS, CULTURED; CYCLIC AMP; DEXAMETHASONE; DINOPROSTONE; FEMALE; GENE EXPRESSION; GLUCOCORTICOIDS; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 4; INTERLEUKIN-1; MALE; MIDDLE AGED; PROTEIN KINASE C; RNA, MESSENGER;

EID: 0030612153     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4644(19970601)65:3<408::AID-JCB10>3.0.CO;2-B     Document Type: Article

References (61)

1. Bennett A, Chen TL, Feldman D, Hintz Rl, Rosenfeld RG (1984): Characterization of insulin-like growth factor I receptors on cultured rat bone cells: Regulation of receptor concentration by glucocorticoids. Endocrinology 115: 1577-1583.
2. Bonin PD, Chiou WJ, McGee JE, Singh JP (1990): Two signal transduction pathways mediate interleukin-1 receptor expression in Balb/c3T3 fibroblasts. J Biol Chem 265:18643-18649.
3. Burton K (1956): A study of the conditions and mechanism of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acid. Biochem J 62:315-323.
4. Case JP, Lafyatis R, Kumkumian GK, Remmers EF, Wilder RL (1990): IL-1 regulation of transin/stromelysin transcription in rheumatoid synovial fibroblasts appears to involve two antagonistic transduction pathways, an inhibitory, and a stimulatory, protein kinase C dependent pathway. J Immunol 145:3755-3761.
5. 2 synthesis by a selective COX-2 inhibitor. Inflammation Res 44(Suppl 3):S273.
6. Chen TL, Chang LY, Bates RL, Perlman AJ (1991): Dexamethasone and 1,25-dihydroxyvitamin D3 modulation of insulin-like growth factor binding proteins in rat osteoblast-like cell cultures. Endocrinology 128:73-80.
7. Cohen P, Graves HCB, Peehl DM, Kamarei M, Giudice LC, Rosenfeld RG (1991): Prostate specific antigen (PSA) is an IGF binding protein-3 (IGFBP-3) protease found in seminal plasma. J Clin Endocrinol Metab 73:391-407.
8. Conover CA, Kiefer MC, Zapf J (1993): Posttranslational regulation of insulin-like growth factor binding protein-4 in normal and transformed human fibroblasts. Insulin-like growth factor dependence and biological studies. J Clin Invest 91:1129-1137.
9. Conover CA, Durham SK, Zapf J, Masiarz FR, Kiefer MC (1995): Cleavage analysis of insulin-like growth factor (IGF)-dependent IGF-binding protein-4 proteolysis and expression of protease-resistant IGF-binding protein-4 mutants. J Biol Chem 270:4395-4400.
10. Conti M, Catherine Jin SL, Monaco L, Repaske DR, Swinnen JV (1991): Hormonal regulation of cyclic nucleotide phosphodiesterases. Endocrine Rev 12:218-233.
11. Cubbage ML, Suwanichkul A, Powell DR (1990): Insulin-like growth factor binding protein-3: Organization of the human chromosomal gene and demonstration of promoter activity. J Biol Chem 265:12642-12649.
12. Dekker LV, Palmer RH, Parker PJ (1995): The protein kinase C and the protein kinase C related gene families. Curr Opin Struct Biol 5:396-402.
13. DeMellow JSM, Baxter RC (1988): Growth hormone dependent insulin-like growth factor binding protein both inhibits and potentiates IGF-1 stimulated DNA synthesis in skin fibroblasts. Biochem Biophys Res Commun 156:199-204.
14. Di Battista JA, Martel-Pelletier J, Wosu LO, Sandor T, Antakly T, Pelletier JP (1991a): Glucocorticoid receptor mediated inhibition of interleukin-1 stimulated neutral metalloprotease synthesis in normal human chondrocytes. J Clin Endocrinol Metab 72:316-326.
15. Di Battista JA, Martel-Pelletier J, Cloutier JM, Pelletier J-P (1991b): Modulation of glucocorticoid receptor expression in human articular chondrocytes by cAMP and prostaglandins. J Rheumatol 18:102-105.
16. Di Battista JA, Martel-Pelletier J, Antakly T, Tardif G, Cloutier J-M, Pelletier JP (1993): Reduced expression of glucocorticoid receptor levels in human osteoarthritic chondrocytes. Role in the suppression of metalloprotease synthesis. J Clin Endocrinol Metab 76:1128-1134.
17. 1 inhibit the cytokine-stimulated expression of metalloproteinases in normal human synovial fibroblasts: Mediation by cyclic AMP signalling pathway. Lab Invest 71:270-278.
18. Di Battista JA, Pelletier JP, Zafarullah M, Fujimoto N, Obata K, Martel-Pelletier J (1995): Coordinate regulation of matrix metalloproteases and tissue inhibitor of metalloproteinase expression in human synovial fibroblasts. J Rheumatol 22:123-128.
19. 2 up-regulates insulin-like growth factor binding-3 expression and synthesis in human articular chondrocytes by a cAMP-independent pathway: Role of calcium and protein kinase A and C. J Cell Biochem 62:1-14.
20. 2 stimulates incorporation of proline into collagenase digestible proteins in human articular chondrocytes: Identification of an effector autocrine loop involving insulin-like growth factor-I. Mol Cell Endocrinol 123:27-35.
21. Donnelly MJ, Holly JMP (1996): The role of IGFBP-3 in the regulation of IGFBP-4 proteolysis. J Endocrinol 149:R1-R7.
22. Doré S, Pelletier JP, Di Battista JA, Tardif G, Brazeau P, Martel-Pelletier J (1994): Human OA chondrocytes possess an increased number of binding sites to IGF-1 but are irresponsive to its stimulation: Possible role of binding proteins. Arthritis Rheum 37:253-263.
23. Fowlkes JL, Freemark M (1992): Evidence for a novel insulin-like growth factor (IGF)-dependent protease regulating IGF-binding protein-4 in dermal fibroblasts. Endocrinology 131:2071-2076.
24. Fowlkes JL, Serra DM, Rosenberg CK, Thrailkill KM (1995): Insulin-like growth factor (IGF)-binding protein-3 functions as an IGF-reversible inhibitor of IGFBP-4 proteolysis. J Biol Chem 270:27481-27488.
25. Franchimont P, Bassler C (1991): Effects of hormones and local growth factors on articular chondrocyte metabolism. J Rheumatol 18 (Suppl 27):68-70.
26. Gao L, Ling N, Shimasaki S (1993): Structure of the rat insulin-like growth factor binding protein-4 gene. Biochem Biophys Res Commun 190:1053-1059.
27. Goldring MB, Suen LF (1994): Immortalized human chondrocytes: A model of osteoarthritis. Osteoarthritis Cartilage 2(Suppl 1): 33.
28. Hidaka H, Sasaki Y, Tanaka T, Endo T, Ohno S, Fujii Y, Nagata T (1981): N-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide, a calmodulin antagonist, inhibits cell proliferation. Proc Natl Acad Sei USA 78:4354-4357.
29. Hossenlopp P, Seurin D, Segovia-Quinson B, Hardouin S, Binoux M (1986): Analysis of serum insulin-like growth factor binding proteins using Western blotting: Use of a method for titration of the binding proteins and competitive binding studies. Anal Biochem 154:138-143.
30. Inagaki M, Gonda Y, Nishizawa K, Kitamura S, Sato C, Ando S, Tanabe K, Kikuchi K, Tsuiki S, Nishi Y (1990): Phosphorylation sites linked to glial filament disassembly in vitro locate in a non-α-helical head domain. J Biol Chem 265:4722-4729.
31. Irie A, Segi E, Sugimoto Y, Ichikawa A, Negishi M (1994): Mouse prostaglandin E receptor EP3 subtype mediates calcium signals via Gi in cDNA transfected chinese hamster ovary cells. Biochem Biophys Res Commun 204:303-309.
32. Jones JI, Clemmons DR (1995): Insulin-like growth factors and their binding proteins: Biological actions. Endocrine Rev 16:3-34.
33. Kanety H, Shimon I, Ehrenfeld M, Israeli A, Pariente C, Karasik A (1996): Insulin-like growth factor-I and its binding proteins 3 and 4 are increased in human synovial fluid. J Rheumatol 23:815-818.
34. Kiley SC, Jaken S (1994): Protein kinase C: interactions and consequences. Trends Cell Biol 4:223-227.
35. Kream BE, Petersen DN, Raisz LG (1990): Cortisol enhances the anabolic effects of insulin-like growth factor I on collagen synthesis and procollagen messenger ribonucleic acid levels in cultured 21-day fetal rat calvariae. Endocrinology 126:1576-1583.
36. Lamson G, Cohen P, Giudice LC, Fielder PJ, Oh Y, Hintz RL, Rosenfeld RG (1993): Proteolysis of IGF BP-3 may be a common regulatory mechanism of IGF-1 action in vivo. Growth Regul 3:91-95.
37. LaTour D, Mohan S, Linkhart TA, Baylink DJ, Strong DD (1990): Inhibitory insulin-like growth factor binding protein: Cloning, complete sequence, and physiological regulation. Mol Endocrinol 4:1806-1814.
38. Lucas M, Sanchez-Margalet, V (1995): Protein kinase involvement in apoptosis. Gen Pharmacol 26:881-887.
39. Malemud CJ (1993): Role of growth factors in cartilage metabolism. In Moskowitz RW (ed): "Rheumatic Disease Clinics in North America." Philadelphia: W.B. Saunders Company, pp 569-580.
40. Mankin HJ (1974): The reaction of articular cartilage to injury and osteoarthritis. N Engl J Med 291:1285-1292.
41. Martel-Pelletier J, McCollum R, DiBattista JA, Faure MP, Chin J, Cloutier JM, Pelletier JP (1992): The interleukin-1 receptor in normal and osteoarthritic human articular chondrocytes: Identification as the type-1 receptor and analysis of binding kinetics and biologic function. Arthritis Rheum 35:530-540.
42. Matsumoto T, Gargosky SE, Iwasaki K, Rosenfeld RG (1996): Identification and characterization of insulin-like growth factors (IGFs), IGF binding proteins (IGFBPs), and IGFBP proteases in human synovial fluid. J Clin Endocrinol Metab 81:150-155.
43. 2 in primary rat osteoblasts. J Biol Chem 271:6666-6671.
44. Munoz E, Beutner U, Zubiaga A, Huber BT (1990): Il-1 activates two separate signal transduction pathways in T helper type II cells. J Immunol 144:964-969.
45. Oh Y, Muller HL, Lamson G, Rosenfeld RG (1993a): Insulin-like growth factor (IGF)-independent action of IGF-binding protein-3 in Hs578T human breast cancer cells. Cell surface binding, growth inhibition. J Biol Chem 268:14964-14971.
46. Oh Y, Muller HL, Pham H, Rosenfeld RG (1993b): Demonstration of receptors for insulin-like growth factor binding protein-3 on Hs578T human breast cancer cells. J Biol Chem 268:26045-26048.
47. Okazaki R, Riggs BL, Conover CA (1994): Glucocortioid regulation of insulin-like growth factor binding protein expression in normal human osteoblast-like cells. Endocrinology 134:126-132.
48. Olney RC, Wilson DM, Mohtai M, Fielder PJ, Smith RL (1995): Interleukin-1 and tumor necrosis factor α increase insulin-like growth factor-binding protein-3 (IGFBP-3) production and IGFBP-3 protease activity in human articular chondrocytes. J Endocrinol 146:279-286.
49. Olney RC, Tsuchiya K, Wilson DM, Montai M, Maloney WJ, Schurman DJ, Smith RL (1996): Chondrocytes from osteoarthritic cartilage have increased expression of insulin-like growth factor I (IGF-1) and IGF-binding protein-3 (IGFBP-3) and -5, but not IGF-II or IGFBP-4. J Clin Endocrinol Metab 81:1096-1103.
50. 2 in osteoblast cells. Endocrinology 137:2375-2382.
51. Pelletier JP, Martel-Pelletier J (1989): Protective effects of corticosteroids on cartilage lesions and osteophyte formation in the Pond-Nuki dog model of osteoarthritis. Arthritis Rheum 2:181-193.
52. Rechler MM (1995): Insulin-like growth factor binding proteins. In Weintraub BD (ed): "Molecular Endocrinology: Basic Concepts and Clinical Correlations." New York: Raven Press, Ltd., pp 155-180.
53. Ryan MC, Sieraski M, Sandell L (1990): The human type II collagen gene: Identification of an additional protein-coding domain and location of potential regulatory sequences in the promoter and first intron. Genomics 8:41-48.
54. Sandell LJ, Dudek EJ (1988): Insulin-like growth factor I stimulates type II collagen gene expression in cultured chondrocytes. Transact 35th Annu Meet Orthopaed Res Soc Atlanta, p 300.
55. Sette C, Iona S, Conti M (1994): The short-term activation of a rolipram-sensitive, cAMP specific phosphodiesterase by thyroid-stimulating hormone in thyroid FRTL-5 cells is mediated by a cAMP-dependent phosphorylation. J Biol Chem 269:9245-9252.
56. Shimasaki S, Uchiyama F, Shimonaka N, Ling N (1990): Molecular cloning of the cDNAs encoding a novel insulin-like growth factor-binding protein from rat and human. Mol Endocrinol 4:1451-1458.
57. Tesch GH, Handley CJ, Cornell HJ, Herington AC (1992): Effects of free and bound insulin-like growth factors on proteoglycan metabolism in articular cartilage explants. J Orthop Res 10:14-22.
58. Valentinis B, Bhala A, DeAngelis T, Baserga R, Cohen P (1995): The human insulin-like growth factor (IGF) binding protein-3 inhibits the growth of fibroblasts with a targeted disruption of the IGF-1 receptor gene. Mol Endocrinol 9:361-367.
59. Wang L, Balkir R, Horton WEJ (1991): Identification of a cis-acting sequence in the collagen II enhancer required for chondrocyte expression and the binding of a chondrocyte nuclear factor. J Biol Chem 266:19878-19881.
60. Yang YWH, Pioli P, Forelli G, Brandi ML, Rechler MH (1993): Cyclic adenosine monophosphate stimulates insulin-like growth factor binding protein-4 and its messenger ribonucleic acid in a clonal endothelial cell line. Endocrinology 133:343-351.
61. Yano T, Taura C, Shibata M, Hirono Y, Ando S, Kusubata M, Takahashi T, Inagaki M (1991): A monoclonal antibody to the phosphorylated form of glial fibrillary acidic protein: Application to a non-radioactive method for measuring protein kinase activities. Biochem Biophys Res Commun 175:1144-1151.